Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack mutant tumor cells, has transformed the treatment landscape for patients battling cancer, which emerges from the progressive ...
Oct 27, 2022
0
19
Blood transfusion is a vital and lifesaving intervention in a broad range of scenarios, from trauma response to cancer treatment. However, it is not entirely without risk.
Oct 24, 2022
0
45
Numerous studies have shown that drugs called immune checkpoint inhibitors can boost the immune system's response against various cancers. Now a phase II clinical trial has demonstrated that patients with a serious form of ...
Oct 24, 2022
0
4
Scientists from the Heidelberg Institute for Theoretical Studies (HITS), the German Cancer Research Center (DKFZ), the Heidelberg University Hospital and Heidelberg University have established INDICATE, an international collaborative ...
Oct 21, 2022
0
4
Cancers are the second leading cause of death in the world, after cardiovascular diseases. Their seriousness lies in their diversity—some can be effectively treated with surgery, chemotherapy and radiotherapy, while others ...
Oct 20, 2022
0
2
Researchers have uncovered cancer-like genetic mutations in the affected cells of people with scleroderma, pointing the way to potential new ways to treat the debilitating and sometimes fatal skin and connective tissue disease.
Oct 20, 2022
0
15
Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Germany, were able to identify a new approach for the therapy of colorectal cancer (CRC) as part of an interdisciplinary project of the LOEWE Center Frankfurt Cancer ...
Oct 20, 2022
0
158
The human immune system has a powerful ability to ward off invaders, from viruses and bacteria to cancer cells. But it also has a series of checks and balances, molecular brakes to prevent unnecessary immune responses. In ...
Oct 18, 2022
0
40
Virginia Tech researchers from the Department of Biomedical Engineering and Mechanics and the Department of Biochemistry have discovered a characteristic of a common oral bacterium that relocates to pancreatic cancer tumors ...
Oct 18, 2022
0
49
Researchers from the University of Rhode Island and Yale University have demonstrated a promising new approach to delivering immunotherapy agents to fight cancer.
Oct 18, 2022
0
35
